← FDA DRUG APPROVALS

FDA ANDA · ANDA204197

CELECOXIB

Sponsor: APOTEX

APPLICATION
ANDA204197
TYPE
ANDA
ORIGINAL APPROVAL
2015-06-02
LATEST ACTION
2025-02-26
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription

Products

CELECOXIBPrescription
CELECOXIB 100MG · CAPSULE · ORAL
CELECOXIBPrescription
CELECOXIB 200MG · CAPSULE · ORAL
CELECOXIBPrescription
CELECOXIB 50MG · CAPSULE · ORAL

Approval history

2025-02-26Labeling · Supplement 16 · standardAP
2025-02-26Labeling · Supplement 13 · standardAP
2019-10-01Labeling · Supplement 7 · standardAP
2019-07-25Labeling · Supplement 6 · standardAP
2016-09-16Labeling · Supplement 2 · standardAP
2016-09-16Labeling · Supplement 1 · standardAP
2015-06-02UNKNOWN · OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →